<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1561-3194</journal-id>
<journal-title><![CDATA[Revista de Ciencias Médicas de Pinar del Río]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Ciencias Médicas]]></abbrev-journal-title>
<issn>1561-3194</issn>
<publisher>
<publisher-name><![CDATA[Editorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1561-31942023000600022</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Caracterización clínica e histopatológica de pacientes con cáncer de ovario]]></article-title>
<article-title xml:lang="en"><![CDATA[Clinical and histopathological characterization of patients with ovarian cancer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Otero-Leyva]]></surname>
<given-names><![CDATA[Maday]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Almeida-Esquivel]]></surname>
<given-names><![CDATA[Yudelky]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Piñón-García]]></surname>
<given-names><![CDATA[Karell]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Creagh-García]]></surname>
<given-names><![CDATA[Johenis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ramos-García]]></surname>
<given-names><![CDATA[Daniel Ernesto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad de Ciencias Médicas de Camagüey Hospital Universitario &#8220;Manuel Ascunce Domenech&#8221; ]]></institution>
<addr-line><![CDATA[Camagüey ]]></addr-line>
<country>Cuba</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>10</month>
<year>2023</year>
</pub-date>
<volume>27</volume>
<numero>5</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S1561-31942023000600022&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S1561-31942023000600022&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S1561-31942023000600022&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: el cáncer de ovario es una enfermedad que representa un tema de interés en salud pública, porque es una de las neoplasias ginecológicas con mayor mortalidad en varias partes del mundo. Se considera uno de los cánceres ginecológicos más frecuentes a nivel global, ocupando el tercer lugar después de cuello y cuerpo uterino.  Objetivo:  caracterizar de forma clínica e histopatológica las pacientes con neoplasias de ovarios.  Métodos:  se realizó un estudio observacional, descriptivo de corte transversal a las pacientes con diagnóstico de cáncer de ovario confirmado por el departamento de Anatomía Patológica del Hospital Universitario &#8220;Manuel Ascunce Domenech&#8221; en la provincia de Camagüey, en el periodo comprendido entre junio de 2020 y junio de 2022. Se trabajó con una muestra de 55 pacientes y se utilizó la estadística descriptiva.  Resultados:  las neoplasias de ovarios resultaron frecuentes en las mujeres hipertensas entre 60 y 69 años. Predominaron las pacientes nulíparas y obesas con dolor en bajo vientre y aumento de volumen. La mayor parte de las neoplasias de ovarios eran unilaterales y fueron clasificadas como cistoadenocarcinomas de tipo mucinoso o adenocarcinomas papilares superficiales, en estadios IIIB o IIIA.  Conclusiones:  el cáncer de ovario constituye un problema de salud actual a nivel global, mientras más precoz se haga el diagnóstico histopatológico, mejor será la conducta y el seguimiento postoperatorio y, por ende, más posibilidades de sobrevida tienen las pacientes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  ovarian cancer is a disease that represents a matter of interest in public health, because it is one of the gynecological neoplasms with the highest mortality in several parts of the world. It is considered one of the most frequent gynecological cancers globally, occupying the third place after cervix and uterine body.  Objective:  to clinically and histopathologically characterize patients with ovarian neoplasms.  Methods:  an observational, descriptive, cross-sectional, descriptive study was carried out on patients with ovarian cancer diagnosis confirmed by the Pathological Anatomy Department of the "Manuel Ascunce Domenech" University Hospital in the province of Camagüey, in the period between June 2020 and June 2022. We worked with a sample of 55 patients and descriptive statistics were used.  Results:  ovarian neoplasms were frequent in hypertensive women between 60 and 69 years old. Nulliparous and obese patients with lower abdominal pain and increased volume predominated. Most ovarian neoplasms were unilateral and were classified as mucinous cystoadenocarcinomas or superficial papillary adenocarcinomas, stage IIIB or IIIA.  Conclusions:  ovarian cancer is a current global health problem, the earlier the histopathological diagnosis is made, the better the postoperative behavior and follow-up and, therefore, the more chances of survival for patients.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[NEOPLASIAS OVÁRICAS]]></kwd>
<kwd lng="es"><![CDATA[BIOPSIA]]></kwd>
<kwd lng="es"><![CDATA[MORBILIDAD]]></kwd>
<kwd lng="es"><![CDATA[MORTALIDAD]]></kwd>
<kwd lng="es"><![CDATA[TRATAMIENTO]]></kwd>
<kwd lng="en"><![CDATA[OVARIAN NEOPLASMS]]></kwd>
<kwd lng="en"><![CDATA[BIOPSY]]></kwd>
<kwd lng="en"><![CDATA[MORBIDITY]]></kwd>
<kwd lng="en"><![CDATA[MORTALITY]]></kwd>
<kwd lng="en"><![CDATA[TREATMENT]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Costa Correia]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Coutinho Cabral]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[João Vale]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Luís Santos]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Teratoma Imaturo Ovariano de Grau I: Caso Clínico.]]></article-title>
<source><![CDATA[Rev Gazeta Médica]]></source>
<year>2021</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>49-52.</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dávila Riega]]></surname>
<given-names><![CDATA[KR.]]></given-names>
</name>
</person-group>
<source><![CDATA[Características epidemiológicas de cáncer de ovario primario en pacientes del servicio de ginecología oncológica del instituto regional de enfermedades neoplásicas del sur]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Arequipa ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Católica de Santa María]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Sacoto]]></surname>
<given-names><![CDATA[JA.]]></given-names>
</name>
</person-group>
<source><![CDATA[Estrategias de tratamiento en cáncer de ovario estadio III y IV]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Cuenca ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Católica de Cuenca]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tauste Rubio]]></surname>
<given-names><![CDATA[CM.]]></given-names>
</name>
</person-group>
<source><![CDATA[Medición del impacto de la cirugía de citorreducción en el cáncer de ovario avanzado. Estudio de cohortes retrospectivas]]></source>
<year>2023</year>
<publisher-loc><![CDATA[Navarra ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Pública de Navarra]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[González Fernández]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Morales Yera]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Santana Rodríguez]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Reinoso Padrón]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Heredia Martínez]]></surname>
<given-names><![CDATA[BE.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Caracterización clínico-epidemiológica del cáncer de ovario.]]></article-title>
<source><![CDATA[Rev Finlay]]></source>
<year>2021</year>
<volume>11</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>359-70</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<source><![CDATA[Dirección de registros médicos y estadísticas de salud. Anuario Estadístico de Salud.]]></source>
<year>2020</year>
<publisher-loc><![CDATA[La Habana ]]></publisher-loc>
<publisher-name><![CDATA[MINSAP]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pérez-García]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Sierra-Avendaño]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Barón]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Álvarez-Ojeda]]></surname>
<given-names><![CDATA[OM.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Carcinogénesis de los tumores serosos del ovario: implicaciones quirúrgicas, avances recientes y futuros retos para su diagnóstico y tratamiento.]]></article-title>
<source><![CDATA[Rev Ginecol obstet Méx]]></source>
<year>2018</year>
<volume>86</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>389-400.</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Atallah]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Abd Aziz]]></surname>
<given-names><![CDATA[NH]]></given-names>
</name>
<name>
<surname><![CDATA[Teik]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Shafiee]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Kampan]]></surname>
<given-names><![CDATA[NC.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[New Predictive Biomarkers for Ovarian Cancer.]]></article-title>
<source><![CDATA[Rev Diagnostics]]></source>
<year>2021</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>465</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frías-Sánchez]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Pantoja-Garrido]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rojo-Novo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez-Gallardo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Márquez-Maraver]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Polo-Velasco]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adenocarcinoma sincrónico de alto grado de endometrio y ovario; a propósito de un caso clínico.]]></article-title>
<source><![CDATA[Rev chil obstet ginecol]]></source>
<year>2018</year>
<volume>83</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>394-401.</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Urgell Cuevas]]></surname>
<given-names><![CDATA[W.]]></given-names>
</name>
</person-group>
<source><![CDATA[Modelo de Mejora de la Calidad de la Atención mediante el Ciclo de Deming en un Hospital Oncológico]]></source>
<year>2022</year>
<publisher-loc><![CDATA[Xalapa ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Veracruzana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[AdlC.]]></surname>
<given-names><![CDATA[Álvarez Sánchez]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correlación ultrasonográfica e histopatológica de los tumores de ovario.]]></article-title>
<source><![CDATA[Rev Cubana Obstet Ginecol]]></source>
<year>2010</year>
<volume>36</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>86-96</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dos Santos Junior]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz Pequeno]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Melo Oliveira]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sales da Silva]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[De Souza]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
<name>
<surname><![CDATA[De Oliveira Filho]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical, sonographic and anatomopathological aspects of ovarian teratoma in a heifer.]]></article-title>
<source><![CDATA[Rev Cienc Rural]]></source>
<year>2022</year>
<volume>52</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khanlarkhani]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Azizi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Amidi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Khodarahmian]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Salehi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pazhohan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metabolic risk factors of ovarian cancer: a review.]]></article-title>
<source><![CDATA[Rev JBRA Assist Reprod]]></source>
<year>2022</year>
<volume>26</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>335-347.</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilczy&#324;ski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Paradowska]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies.]]></article-title>
<source><![CDATA[Rev Int J Mol Sci]]></source>
<year>2022</year>
<volume>23</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>2496</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Falzone]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Scandurra]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lombardo]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Gattuso]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lavoro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Distefano]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer.]]></article-title>
<source><![CDATA[Rev Int J Oncol]]></source>
<year>2021</year>
<volume>59</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-14.</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Damián-Aucancela]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Cubillo-Chungata]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
<name>
<surname><![CDATA[Basantes-Fuenmayor]]></surname>
<given-names><![CDATA[PD]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Ruiz]]></surname>
<given-names><![CDATA[MG.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Principales avances en la investigación clínica del cáncer de ovario: una revisión actualizada]]></article-title>
<source><![CDATA[Rev Pol Con]]></source>
<year>2022</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>846-57</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez Reigosa]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Guerrero García]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
<name>
<surname><![CDATA[Esperón Noa]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
<name>
<surname><![CDATA[Linchenat Lambert]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Silveira Pablos]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz Ortega]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer de ovario en el Instituto Nacional de Oncología y Radiobiología de Cuba: 2001 a 2005.]]></article-title>
<source><![CDATA[Rev Cubana Cir]]></source>
<year>2009</year>
<volume>48</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alarcón C JP]]></surname>
<given-names><![CDATA[Sánchez-GL]]></given-names>
</name>
<name>
<surname><![CDATA[Rodríguez ME]]></surname>
<given-names><![CDATA[Díaz TM]]></given-names>
</name>
<name>
<surname><![CDATA[López RR]]></surname>
<given-names><![CDATA[Paris BL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cistoadenocarcinoma de ovario y apéndice.]]></article-title>
<source><![CDATA[Rev Chil Cir]]></source>
<year>2012</year>
<volume>64</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>289-91</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Garrido]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
<name>
<surname><![CDATA[Fredes]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Lobos-González]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Valenzuela-Valderrama]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Vera]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[C.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Current Treatments and New Possible Complementary Therapies for Epithelial Ovarian Cancer.]]></article-title>
<source><![CDATA[Biomedicines]]></source>
<year>2021</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>77</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Khosravi-Shahi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cabezón-Gutiérrez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Custodio-Cabello]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Supervivencia tras cirugía citorreductora de máximo esfuerzo y quimioterapia basada en platino en pacientes con cáncer epitelial de ovario, carcinoma de trompa de Falopio y carcinomatosis peritoneal primaria: experiencia de un Hospital Público Universitario en España]]></article-title>
<source><![CDATA[Rev Gac mex oncol]]></source>
<year>2019</year>
<volume>18</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>18-27.</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
